08.02.2013 Views

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />

to follow the use of HBOT in these ‚nontraditional‛<br />

conditions. This chapter is not designed<br />

to outline the established uses of hyperbaric<br />

<strong>medicine</strong>, which are well published <strong>and</strong><br />

documented. Rather, the purpose is to review the<br />

current literature regarding the use of HBOT for<br />

the treatment of three of our most challenging<br />

conditions: multiple sclerosis, autism, <strong>and</strong> traumatic<br />

brain injury.<br />

Multiple Sclerosis<br />

Clinical Vignette<br />

RW, a 56 year old married white female, began<br />

to have atypical headache approximately 25 years<br />

ago. She presented repeatedly to her primary care<br />

physician over the course of 10 years with<br />

complaint of head <strong>and</strong> neurological changes. Her<br />

husb<strong>and</strong>, an internal <strong>medicine</strong> specialist, sought<br />

expert opinion from a local university with a<br />

specialty head pain clinic. She was given a<br />

diagnosis of ‚complex migraine stroke‛ after having<br />

normal brain studies <strong>and</strong> neurological examinations.<br />

She continuedto experience atypical migraine<br />

headache with subsequent temporary loss of vision<br />

<strong>and</strong> motor function. After approximately 10 years,<br />

she was diagnosed by MRI with relapsing-remitting<br />

multiple sclerosis, based on typical periventricular<br />

white matter changes. Further studies such as<br />

spinal fluid analysis for oligoclonal b<strong>and</strong>ing was<br />

notpursued. She has been treated with a variety<br />

of interferon medications <strong>and</strong> is currently taking<br />

interferon-beta (Rebif), muscle relaxors <strong>and</strong> an<br />

antidepressant. Neuropathic pain is managed with<br />

a Fentanyl patch every 72 hours. Physical exam<br />

findings include obesity <strong>and</strong> right lower extremity<br />

weakness, particularly quadraceps weakness,<br />

necessitating the use of a cane for assistance with<br />

ambulation. The patient’s husb<strong>and</strong> admits to<br />

concerns with her ability to reason <strong>and</strong> emotional<br />

lability. Neuropsychological assessment has not<br />

been performed (Beck Depression Inventory,<br />

Modified Boston Naming Test, MMSE,<br />

Constructional Praxis, <strong>and</strong> Word List Memory as<br />

examples.)<br />

Review of the Literature <strong>and</strong> Discussion<br />

141<br />

Multiple sclerosis (MS), a disease of unknown<br />

etiology, is the ‚most common autoimmune<br />

inflammatory demyelinating disease of the central<br />

nervous system.‛ (5) It is characterized by<br />

inflammation of the central nervous system leading<br />

to nerve demyelination. Ultimately, axon<br />

degeneration leads to clinical manifestations, such<br />

as weakness of extremities, numbness, <strong>and</strong><br />

psychological changes. (6) MS is most commonly<br />

know to affect women of childbearing age of<br />

Northern European lineage, with Northern Irel<strong>and</strong><br />

having the highest per capital population of MS<br />

patients.(7)<br />

The differential diagnosis of MS is fairly broad <strong>and</strong><br />

includes genetic <strong>and</strong> congenital CNS<br />

diseases, inflammatory diseases such as<br />

polyarteritis nodosa, systemic lupus erythematosus<br />

(SLE), Behçet’s disease, Sjögren's disease,<br />

retroviral illness, <strong>and</strong> syphilis. Many of these<br />

conditions can cause similar MRI changes <strong>and</strong><br />

manifest with peculiar neurological symptoms.(8)<br />

The current st<strong>and</strong>ard for diagnosis is the<br />

McDonald criteria. The principle of diagnosis rests<br />

with establishing a pattern of clinical findings <strong>and</strong><br />

MRI changes across both space (different areas<br />

of the CNS) <strong>and</strong> time (symptoms <strong>and</strong> lesions are<br />

evolving). Clinical findings suggestive of the<br />

disease include age of onset between 15 <strong>and</strong> 50<br />

years, a relapsing remitting pattern of neurological<br />

change, optic nerve involvement, <strong>and</strong> fatigue.<br />

The diagnosis does not rely upon laboratory<br />

evidence of the disease.(9) The pathophysiology<br />

of MS revolves around the concept of CNS<br />

vascular inflammation causing disruption of the<br />

blood brain barrier leading to an autoimmune<br />

assault involving the myelin sheaths. This repetitive<br />

demyelination ultimately leads to permanent<br />

neurologic damage <strong>and</strong> subsequent clinical<br />

symptoms.(10)<br />

The cornerstone treatment of MS involves immune<br />

modifying interferon beta-1b (Betaseron) <strong>and</strong><br />

beta-1a (Avalox), <strong>and</strong> glatiramer acetate<br />

(Copaxone). Other treatments focus on relieving<br />

symptoms <strong>and</strong> improving quality of life through the<br />

use ofphysical therapy, occupational therapy, anti-<br />

2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!